Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment

Pigment Cell and Melanoma Research

Volumn 27, Issue 4, 2014, Pages 630-639

  Kotobuki, Yorihisa ^a,b   Yang, Lingli ^a   Serada, Satoshi ^b   Tanemura, Atsushi ^a   Yang, Fei ^a   Nomura, Shintaro ^c   Kudo, Akira ^d   Izuhara, Kenji ^e   Murota, Hiroyuki ^a   Fujimoto, Minoru ^b   Katayama, Ichiro ^a   Naka, Tetsuji ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^e SAGA UNIVERSITY   (Japan)

Author keywords

Malignant melanoma; Periostin; Tumor microenvironment

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA6BETA4 INTEGRIN; ALPHAVBETA5 INTEGRIN; COLLAGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RAG2 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VITRONECTIN RECEPTOR; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNOCKOUT MOUSE; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN FIBROBLAST; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CLINICAL TRIAL; GENETICS; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

MUS;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; HETEROGRAFTS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR MICROENVIRONMENT;

EID: 84902551497     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12245     Document Type: Article

References (39)

1. Asano Y, I.H., Yamane K, J.M., Mimura, Y., and Tamaki, K. (2005). Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J. Immunol. 175, 7708-7718.
2. Atefi, M., von Euw, E., Attar, N. et al. (2011). Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. PLoS ONE 6, e28973.
3. Bao, S., Ouyang, G., Bai, X. et al. (2004). Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5, 329-339.
4. Baril, P., Gangeswaran, R., Mahon, P.C. et al. (2007). Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 26, 2082-2094.
5. Elliott, C.G., Wang, J., Guo, X. et al. (2012). Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J. Cell Sci. 125, 121-132.
6. Erkan, M., Kleeff, J., Gorbachevski, A. et al. (2007). Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132, 1447-1464.
7. Flaherty, K.T., Puzanov, I., Kim, K.B. et al. (2010). Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl. J. Med. 363, 809-819.
8. Gillan, L., Matei, D., Fishman, D.A., Gerbin, C.S., Karlan, B.Y., and Chang, D.D. (2002). Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62, 5358-5364.
9. Guarino, M. (2010). Src signaling in cancer invasion. J. Cell. Physiol. 223, 14-26.
10. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
11. Horiuchi, K., Amizuka, N., Takeshita, S. et al. (1999). Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14, 1239-1249.
12. Inai, K., Norris, R.A., Hoffman, S., Markwald, R.R., and Sugi, Y. (2008). BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev. Biol. 315, 383-396.
13. Kudo, Y., Ogawa, I., Kitajima, S. et al. (2006). Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 66, 6928-6935.
14. Li, J.S., Sun, G.W., Wei, X.Y., and Tang, W.H. (2002). Expression of periostin and its clinicopathological relevance in gastric cancer. World J. Gastroenterol. 13, 5261-5266.
15. Li, G., Oparil, S., Sanders, J.M. et al. (2006). Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis 188, 292-300.
16. Nyberg, P., Salo, T., and Kalluri, R. (2008). Tumor microenvironment and angiogenesis. Front Biosci. 13, 6537-6553.
17. Ontsuka, K., Kotobuki, Y., Shiraishi, H. et al. (2012). Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp. Dermatol. 21, 331-336.
18. Ouyang, G., Liu, M., Ruan, K., Song, G., Mao, Y., and Bao, S. (2009). Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett. 281, 213-219.
19. Polyak, K., and Kalluri, R. (2010). The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb. Perspect. Biol. 2, a003244.
20. Puppin, C., Fabbro, D., Dima, M. et al. (2008). High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J. Endocrinol. 197, 401-408.
21. Quaranta, V. (2002). Motility cues in the tumor microenvironment. Differentiation 70, 590-598.
22. Riener, M.O., Fritzsche, F.R., Soll, C. et al. (2010). Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology 56, 600-606.
23. Sasaki, H., Dai, M., Auclair, D. et al. (2001). Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92, 843-848.
24. Sasaki, H., Sato, Y., Kondo, S. et al. (2002). Expression of the periostin mRNA level in neuroblastoma. J. Pediatr. Surg. 37, 1293-1297.
25. Sasaki, H., Yu, C.Y., Dai, M. et al. (2003). Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res. Treat. 77, 245-252.
26. Serada, S., Fujimoto, M., Ogata, A. et al. (2010). iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann. Rheum. Dis. 69, 770-774.
27. Shao, R., Bao, S., Bai, X. et al. (2004). Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 24, 3992-4003.
28. Shimazaki, M., Nakamura, K., Kii, I. et al. (2010). Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205, 295-303.
29. Soltermann, A., Ossola, R., Kilgus-Hawelski, S. et al. (2008a). N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer 114, 124-133.
30. Soltermann, A., Tischler, V., Arbogast, S. et al. (2008b). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 14, 7430-7437.
31. Takayama, G., Arima, K., Kanaji, T. et al. (2006). Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 118, 98-104.
32. Takeshita, S., Kikuno, R., Tezuka, K., and Amann, E. (1993). Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294(Pt 1), 271-278.
33. Tilman, G., Mattiussi, M., Brasseur, F., van Baren, N., and Decottignies, A. (2007). Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol. Cancer. 6, 80.
34. Tischler, V., Fritzsche, F.R., Wild, P.J. et al. (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 10, 273.
35. Weber, J. (2008). Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). Oncologist 13(Suppl 4), 16-25.
36. Yan, W., and Shao, R. (2006). Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J. Biol. Chem. 281, 19700-19708.
37. Yang, C., Zeisberg, M., Lively, J.C., Nyberg, P., Afdhal, N., and Kalluri, R. (2003). Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 63, 8312-8317.
38. Yang, L., Serada, S., Fujimoto, M. et al. (2012). Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS ONE 7, e41994.
39. Zeisberg, M., Maeshima, Y., Mosterman, B., and Kalluri, R. (2002). Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol. 160, 2001-2008.